Arteriocyte Medical Systems raises $10,000,000

Arteriocyte Medical Systems Inc. gets $10 million investment  The investment from DW Healthcare Partners in Salt Lake City is creating Arteriocyte Medical System Inc. The new company will build on Arteriocyte Inc.’s platform for stem cell therapies to treat ischemia, which is tissue damage caused by lack of blood flow, such as that which occurs during a heart attack.  The investment is expected to enable Arteriocyte Medical to develop and market products to help patients who have cardiac, orthopedic and vascular surgeries